158 related articles for article (PubMed ID: 36903593)
21. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
22. Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities.
Chrienova Z; Nepovimova E; Andrys R; Dolezal R; Janockova J; Muckova L; Fabova L; Soukup O; Oleksak P; Valis M; Korabecny J; Marco-Contelles J; Kuca K
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2605-2620. PubMed ID: 36131624
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Pharmacological Evaluation of
Kumar B; Dwivedi AR; Arora T; Raj K; Prashar V; Kumar V; Singh S; Prakash J; Kumar V
ACS Chem Neurosci; 2022 Jul; 13(14):2122-2139. PubMed ID: 35797244
[TBL] [Abstract][Full Text] [Related]
24. Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution.
Chen PY; Tsai CT; Ou CY; Hsu WT; Jhuo MD; Wu CH; Shih TC; Cheng TH; Chung JG
Mol Med Rep; 2012 Apr; 5(4):1043-8. PubMed ID: 22267207
[TBL] [Abstract][Full Text] [Related]
25. Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif.
Pisani L; Farina R; Soto-Otero R; Denora N; Mangiatordi GF; Nicolotti O; Mendez-Alvarez E; Altomare CD; Catto M; Carotti A
Molecules; 2016 Mar; 21(3):362. PubMed ID: 26999091
[TBL] [Abstract][Full Text] [Related]
26. 4-tert-Pentylphenoxyalkyl derivatives - Histamine H
Łażewska D; Olejarz-Maciej A; Kaleta M; Bajda M; Siwek A; Karcz T; Doroz-Płonka A; Cichoń U; Kuder K; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3596-3600. PubMed ID: 30404719
[TBL] [Abstract][Full Text] [Related]
27. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
29. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
[TBL] [Abstract][Full Text] [Related]
30. First Synthesis of Racemic
Guieu B; Lecoutey C; Legay R; Davis A; Sopkova de Oliveira Santos J; Altomare CD; Catto M; Rochais C; Dallemagne P
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375412
[TBL] [Abstract][Full Text] [Related]
31. Structure-Guided Design of
Svobodova B; Pulkrabkova L; Panek D; Misiachna A; Kolcheva M; Andrys R; Handl J; Capek J; Nyvltova P; Rousar T; Prchal L; Hepnarova V; Hrabinova M; Muckova L; Tosnerova D; Karabanovich G; Finger V; Soukup O; Horak M; Korabecny J
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298087
[TBL] [Abstract][Full Text] [Related]
32. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F
Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401
[TBL] [Abstract][Full Text] [Related]
33. Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets.
Purgatorio R; Kulikova LN; Pisani L; Catto M; de Candia M; Carrieri A; Cellamare S; De Palma A; Beloglazkin AA; Reza Raesi G; Voskressensky LG; Altomare CD
ChemMedChem; 2020 Oct; 15(20):1947-1955. PubMed ID: 32716595
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
[TBL] [Abstract][Full Text] [Related]
35. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.
Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V
Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
37. Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
Sasidharan R; Eom BH; Heo JH; Park JE; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Manju SL; Mathew B; Kim H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):188-197. PubMed ID: 33430657
[TBL] [Abstract][Full Text] [Related]
38. Preliminary studies of 1,5-benzoxazepine derivatives as potential histamine H
Stefaniak-Napieralska M; Walczyński K; Iwan M; Korga-Plewko A; Szałaj N; Więckowska A; Staszewski M
Future Med Chem; 2024 Feb; 16(3):197-204. PubMed ID: 38189171
[No Abstract] [Full Text] [Related]
39. Progress in the development of histamine H
Łażewska D; Kieć-Kononowicz K
Expert Opin Ther Pat; 2018 Mar; 28(3):175-196. PubMed ID: 29334795
[TBL] [Abstract][Full Text] [Related]
40. (
Jin QH; Zhang LP; Zhang SS; Zhuang DN; Zhang CY; Zheng ZJ; Guan LP
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
